Leveraging continuous glucose monitoring as a catalyst for behaviour change: a scoping review

Michelle R. Jospe, Kelli M. Richardson, Ahlam A. Saleh, Lauren C. Bohlen, Jacob Crawshaw, Yue Liao, Kristin Konnyu, Susan M. Schembre* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Background: Amidst the escalating prevalence of glucose-related chronic diseases, the advancements, potential uses, and growing accessibility of continuous glucose monitors (CGM) have piqued the interest of healthcare providers, consumers, and health behaviour researchers. Yet, there is a paucity of literature characterising the use of CGM in behavioural intervention research. This scoping review aims to describe targeted populations, health behaviours, health-related outcomes, and CGM protocols in randomised controlled trials (RCTs) that employed CGM to support health behaviour change. Methods: We searched Ovid MEDLINE, Elsevier Embase, Cochrane Central Register of Controlled Trials, EBSCOhost PsycINFO, and ProQuest Dissertations & Theses Global from inception to January 2024 for RCTs of behavioural interventions conducted in adults that incorporated CGM-based biological feedback. Citation searching was also performed. The review protocol was registered (https://doi.org/10.17605/OSF.IO/SJREA). Findings: Collectively, 5389 citations were obtained from databases and citation searching, 3995 articles were screened, and 31 were deemed eligible and included in the review. Most studies (n = 20/31, 65%) included adults with type 2 diabetes and reported HbA1c as an outcome (n = 29/31, 94%). CGM was most commonly used in interventions to target changes in diet (n = 27/31, 87%) and/or physical activity (n = 16/31, 52%). 42% (n = 13/31) of studies provided prospective CGM-based guidance on diet or activity, while 61% (n = 19/31) included retrospective CGM-based guidance. CGM data was typically unblinded (n = 24/31, 77%) and CGM-based biological feedback was most often provided through the CGM and two-way communication (n = 12/31, 39%). Communication typically occurred in-person (n = 13/31, 42%) once per CGM wear (n = 13/31; 42%). Conclusions: This scoping review reveals a predominant focus on diabetes in CGM-based interventions, pointing out a research gap in its wider application for behaviour change. Future research should expand the evidence base to support the use of CGM as a behaviour change tool and establish best practices for its implementation. Trial registration: doi.org/10.17605/OSF.IO/SJREA.

Original languageEnglish
Article number74
Number of pages23
JournalInternational Journal of Behavioral Nutrition and Physical Activity
Volume21
DOIs
Publication statusPublished - 10 Jul 2024

Bibliographical note

The authors would like to thank the student interns for their support in
screening articles for inclusion in the prior biological feedback scoping review,
which laid the foundation for the present review.

Data Availability Statement

The dataset supporting the conclusions of this review is currently available in
the Zenodo repository, https:// doi. org/ 10. 5281/ zenodo. 10822 226. The dataset
contains references to the included articles, as well as the data extracted for
each study.

Keywords

  • Behaviour change
  • Biomarkers
  • Blood glucose self-monitoring
  • Continuous glucose monitoring
  • Feedback

Fingerprint

Dive into the research topics of 'Leveraging continuous glucose monitoring as a catalyst for behaviour change: a scoping review'. Together they form a unique fingerprint.

Cite this